NCT04494360View on ClinicalTrials.gov

Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD

CompletedOBSERVATIONAL
Enrollment

830

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions
Healthy
Interventions
OTHER

No intervention

No investigational medicinal product will be administered as a part of this study.

Trial Locations (3)

33024

Research Centers of America, LLC, Hollywood

66219

PRA Health Sciences, Lenexa

78240

Endeavor Clinical Trials, LLC, San Antonio

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04494360 - Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD | Biotech Hunter | Biotech Hunter